Competitive Bidding Relief Act

Issues related to durable medical equipment including competitive bidding, power wheelchairs, oxygen, non-invasive ventilators, diabetic supplies, negative pressure wound therapy, Medicare audits, trade and sequestration; Issues related to Medicare sequestration paygo relief legislation; Issues related to Medicare titanium/carbon upgrade legislation, and Medicare coverage of seat elevation and standing features; H.R. 2005 - DMEPOS Relief Act of 2025 (issues related to Medicare reimbursement cuts in DME noncompetitive bidding areas); S. 2951 - Competitive Bidding Relief Act (issues related to Medicare reimbursement cuts in DME noncompetitive bidding areas); Issues related to H.R. 1703/S. 247 - Choices for Increased Mobility Act of 2025; Issues related to H.R. 2902/S. 1406 - SOAR Act of 2025; Issues related to S. 4037 - Diabetes Act.

Client expense: $390,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE

Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.

Client expense: $200,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Support DMEPOS Relief / Competitive Bidding Fix (S.2951/ H.R.2005)

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Healthcare supply chain and resiliency, issues related to federal Medicare/Medicaid reimbursement for medical products, DMEPOS Relief Act of 2025/Competitive Bidding Relief Act (H.R. 2005/S. 2951), Choices For Increased Mobility Act (H.R. 1703/S. 247), Supplemental Oxygen Access Reform Act of 2025 (H.R. 2902/S. 1406), Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services (DIABETES) Act (S. 4037), The Medicare Advantage Improvement Act of 2026 (S. 4384/H.R. 8375), The Improving Access to Medicare Coverage Act (S. 4641/H.R. 3954), The Ensuring Seniors Access to Quality Care Act (S.4467/H.R. 7096)

Client expense: $400,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)

Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Issues related to Medicare durable medical equipment competitive bidding. Issues related to competitive bidding, including S. 4037, the DIABETES Act. Issues related to competitive bidding and payment rates in non-competitive bidding areas, including H.R. 2005 / S. 2951, the Competitive Bidding Relief Act of 2025. Issues related to titanium/carbon wheelchair upgrades, including S. 247 / H.R. 1703, the Choices for Increased Mobility Act of 2025. Issues related to Medicare oxygen therapy services, including H.R. 2902 / S. 1406, the SOAR Act. Issues related to regulatory relief and program integrity.

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE

Issues related to durable medical equipment including competitive bidding, power wheelchairs, oxygen, non-invasive ventilators, diabetic supplies, negative pressure wound therapy, Medicare audits, trade and sequestration; Issues related to Medicare sequestration paygo relief legislation; Issues related to Medicare titanium/carbon upgrade legislation, and Medicare coverage of seat elevation and standing features; H.R. 2005 - DMEPOS Relief Act of 2025 (issues related to Medicare reimbursement cuts in DME noncompetitive bidding areas); S. 2951 - Competitive Bidding Relief Act (issues related to Medicare reimbursement cuts in DME noncompetitive bidding areas); Issues related to H.R. 1703/S. 247 - Choices for Increased Mobility Act of 2025; Issues related to H.R. 2902/S. 1406 - SOAR Act of 2025; Issues related to S. 4037 - Diabetes Act.

Client expense: $360,000 · Firm income: Not reported

Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.

Client expense: $250,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.

Client expense: $250,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Issues related to durable medical equipment including competitive bidding, power wheelchairs, oxygen, non-invasive ventilators, diabetic supplies, negative pressure wound therapy, Medicare audits, trade and sequestration; Issues related to Medicare sequestration paygo relief legislation; Issues related to Medicare titanium/carbon upgrade legislation, and Medicare coverage of seat elevation and standing features; H.R. 2005- DMEPOS Relief Act of 2025 (issues related to Medicare reimbursement cuts in DME noncompetitive bidding areas); S. 2951 - Competitive Bidding Relief Act (issues related to Medicare reimbursement cuts in DME noncompetitive bidding areas); Issues related to H.R. 1703/S. 247 - Choices for Increased Mobility Act of 2025; Issues related to H.R. 2902/S. 1406 - SOAR Act of 2025; Issues related to S. 4037 - Diabetes Act.

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Support DMEPOS Relief / Competitive Bidding Fix (S.2951/ H.R.2005)

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to access to home medical equipment and related reimbursement (i.e., the "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4307) and the "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, the "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels. Issues related to continuous glucose monitors.

Client expense: Not reported · Firm income: $80,000

Government targets: HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE

Issues related to durable medical equipment including competitive bidding, power wheelchairs, oxygen, non-invasive ventilators, diabetic supplies, negative pressure wound therapy, Medicare audits, and sequestration; Issues related to Medicare sequestration paygo relief legislation; Issues related to Medicare titanium/carbon upgrade legislation, and Medicare coverage of seat elevation and standing features; H.R. 2005- DMEPOS Relief Act of 2025 (issues related to Medicare reimbursement cuts in DME noncompetitive bidding areas); S. 2951 - Competitive Bidding Relief Act (issues related to Medicare reimbursement cuts in DME noncompetitive bidding areas); Issues related to H.R. 1703/S. 247 - Choices for Increased Mobility Act of 2025; Issues related to H.R. 2902/S. 1406 - SOAR Act of 2025; Issues related to S. 4037 - Diabetes Act.

Client expense: $480,000 · Firm income: Not reported

Issues related to access to home medical equipment and related reimbursement (i.e., the "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4307) and the "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, the "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.

Client expense: $280,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to Medicare durable medical equipment competitive bidding. Issues related to competitive bidding, including S. 4037, the DIABETES Act. Issues related to competitive bidding and payment rates in non-competitive bidding areas, including H.R. 2005 / S. 2951, the Competitive Bidding Relief Act of 2025. Issues related to titanium/carbon wheelchair upgrades, including S. 247 / H.R. 1703, the Choices for Increased Mobility Act of 2025. Issues related to Medicare oxygen therapy services, including H.R. 2902 / S. 1406, the SOAR Act. Issues related to regulatory relief and program integrity.

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE

Issues related to durable medical equipment including competitive bidding, power wheelchairs, oxygen, non-invasive ventilators, diabetic supplies, negative pressure wound therapy, Medicare audits, and sequestration; Issues related to Medicare sequestration paygo relief legislation; Issues related to Medicare titanium/carbon upgrade legislation, and Medicare coverage of seat elevation and standing features; H.R. 2005- DMEPOS Relief Act of 2025 (issues related to Medicare reimbursement cuts in DME noncompetitive bidding areas); S. 2951 - Competitive Bidding Relief Act (issues related to Medicare reimbursement cuts in DME noncompetitive bidding areas); Issues related to H.R. 1703/S. 247 - Choices for Increased Mobility Act of 2025; Issues related to H.R. 2902/S.1406 - SOAR Act of 2025; Issues related to S.4037 Diabetes Act.

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Support DMEPOS Relief / Competitive Bidding Fix (S.2951/ H.R.2005)

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to access to home medical equipment and related reimbursement (i.e., DMEPOS Relief Act of 2025 [H.R. 2005, S. 2951], competitive bidding and the Supplemental Oxygen Access Reform [SOAR] Act of 2025 [H.R. 2902, S. 1406]); promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement.

Client expense: $240,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Office of the Vice President of the United States, SENATE

Issues related to durable medical equipment including competitive bidding, power wheelchairs, oxygen, non-invasive ventilators, diabetic supplies, negative pressure wound therapy, Medicare audits, and sequestration; Issues related to Medicare sequestration paygo relief legislation; Issues related to Medicare titanium/carbon upgrade legislation, and Medicare coverage of seat elevation and standing features; H.R. 2005- DMEPOS Relief Act of 2025 (issues related to Medicare reimbursement cuts in DME noncompetitive bidding areas); S. 2951 - Competitive Bidding Relief Act (issues related to Medicare reimbursement cuts in DME noncompetitive bidding areas); Issues related to H.R. 1703/S. 247 - Choices for Increased Mobility Act of 2025; Issues related to H.R. 2902/S.1406 - SOAR Act of 2025.

Client expense: $440,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE

Issues related to Medicare durable medical equipment competitive bidding. Issues related to competitive bidding and payment rates in non-competitive bidding areas, including H.R. 2005 / S. 2951, the Competitive Bidding Relief Act of 2025. Issues related to titanium/carbon wheelchair upgrades, including S. 247/H.R. 1703, the Choices for Increased Mobility Act of 2025. Issues related to Medicare oxygen therapy services. Issues related to regulatory relief and program integrity.

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE

Issues pertaining to durable medical equipment including competitive bidding, power wheelchairs, oxygen, non-invasive ventilators, diabetic supplies, negative pressure wound therapy, Medicare audits, and sequestration; Issues related to Medicare sequestration paygo relief legislation; Issues related to Medicare titanium/carbon upgrade legislation, and Medicare coverage of seat elevation and standing features; H.R. 2005- DMEPOS Relief Act of 2025 (issues related to Medicare reimbursement cuts in DME noncompetitive bidding areas); S. 2951 - A bill to direct the Secretary of Health and Human Services to provide for certain adjustments to Medicare payment for items of durable medical equipment that were formerly included in round 2021 of the DMEPOS competitive bidding program (issues related to Medicare reimbursement cuts in DME noncompetitive bidding areas); H.R. 1703/S. 247 - Choices for Increased Mobility Act of 2025; H.R. 2902/S.1406 - The SOAR Act.

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Support DMEPOS Relief / Competitive Bidding Fix (S.2951/ H.R.2005)

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues pertaining to durable medical equipment including competitive bidding, power wheelchairs, oxygen, non-invasive ventilators, diabetic supplies, negative pressure wound therapy, Medicare audits, and sequestration; Issues related to Medicare sequestration paygo relief legislation; Issues related to Medicare titanium/carbon upgrade legislation, and Medicare coverage of seat elevation and standing features; H.R. 2005- DMEPOS Relief Act of 2025 (issues related to Medicare reimbursement cuts in DME noncompetitive bidding areas); S. 2951 - A bill to direct the Secretary of Health and Human Services to provide for certain adjustments to Medicare payment for items of durable medical equipment that were formerly included in round 2021 of the DMEPOS competitive bidding program (issues related to Medicare reimbursement cuts in DME noncompetitive bidding areas); H.R. 1703/S. 247 - Choices for Increased Mobility Act of 2025.

Client expense: $300,000 · Firm income: Not reported

Issues related to Medicare durable medical equipment competitive bidding. Issues related to competitive bidding and payment rates in non-competitive bidding areas, including H.R. 2005 / S. 2951, the Competitive Bidding Relief Act of 2025. Issues related to titanium/carbon wheelchair upgrades, including S. 247/H.R. 1703, the Choices for Increased Mobility Act of 2025. Issues related to Medicare coverage of non-invasive ventilators. Issues related to regulatory relief and program integrity.

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE

Issues pertaining to durable medical equipment including competitive bidding, power wheelchairs, oxygen, non-invasive ventilators, diabetic supplies, negative pressure wound therapy, Medicare audits, and sequestration; Issues related to Medicare sequestration paygo relief legislation; Issues related to Medicare titanium/carbon upgrade legislation, and Medicare coverage of seat elevation and standing features; H.R. 2005/S.2951- DMEPOS Relief Act of 2025 (issues related to Medicare reimbursement cuts in DME noncompetitive bidding areas); H.R. 1703/S. 247 - Choices for Increased Mobility Act of 2025.

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE